A Tailorable In Situ Light-Activated Biodegradable Vascular Scaffold

Mazen S. Albaghdadi, Jian Yang, Jessica H. Brown, Neel A. Mansukhani, Guillermo A. Ameer, Melina R. Kibbe

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Biodegradable vascular scaffolds (BVS) are novel treatments for obstructive atherosclerotic cardiovascular disease developed to overcome the limitations of traditional metallic drug-eluting stents. The mechanical properties of bioabsorbable polymers used for the production of novel BVS are a key consideration for the clinical translation of this emerging technology. Herein, the authors describe the engineering of an in situ light-activated vascular scaffold (ILVS) comprised of a biodegradable citric acid-based elastomeric polymer, referred to as methacrylated polydiol citrate (mPDC) and a diazeniumdiolate chitosan nitric oxide donor (chitoNO). In vitro studies demonstrate that the mechanical properties of the ILVS can be tailored to meet or exceed those of commercially available self-expanding bare metal stents (BMS). The radial compression strength of the ILVS is higher than that of a BMS despite undergoing degradation at physiologic conditions for 7 months. ILVS containing chitoNO provides sustained supraphysiologic levels of NO release. Finally, ILVS is successfully cast in porcine arteries ex vivo using a custom designed triple balloon catheter, demonstrating translational potential. In conclusion, these data demonstrate the ability of an ILVS to provide tunable mechanical properties and drug-delivery capabilities for the vasculature and thereby support mPDC as a promising material for the development of novel BVS platforms.

Original languageEnglish (US)
Article number1600243
JournalAdvanced Materials Technologies
Volume2
Issue number4
DOIs
StatePublished - Jan 1 2017

Fingerprint

Scaffolds
Stents
Citric Acid
Nitric Oxide Donors
Nitric oxide
Chitosan
Mechanical properties
Polymers
Metals
Catheters
Balloons
Citric acid
Drug delivery
Degradation
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Materials Science(all)
  • Mechanics of Materials
  • Industrial and Manufacturing Engineering

Cite this

Albaghdadi, M. S., Yang, J., Brown, J. H., Mansukhani, N. A., Ameer, G. A., & Kibbe, M. R. (2017). A Tailorable In Situ Light-Activated Biodegradable Vascular Scaffold. Advanced Materials Technologies, 2(4), [1600243]. https://doi.org/10.1002/admt.201600243
Albaghdadi, Mazen S. ; Yang, Jian ; Brown, Jessica H. ; Mansukhani, Neel A. ; Ameer, Guillermo A. ; Kibbe, Melina R. / A Tailorable In Situ Light-Activated Biodegradable Vascular Scaffold. In: Advanced Materials Technologies. 2017 ; Vol. 2, No. 4.
@article{b4cce5c0c8bf47e4b771ecc2f65488ab,
title = "A Tailorable In Situ Light-Activated Biodegradable Vascular Scaffold",
abstract = "Biodegradable vascular scaffolds (BVS) are novel treatments for obstructive atherosclerotic cardiovascular disease developed to overcome the limitations of traditional metallic drug-eluting stents. The mechanical properties of bioabsorbable polymers used for the production of novel BVS are a key consideration for the clinical translation of this emerging technology. Herein, the authors describe the engineering of an in situ light-activated vascular scaffold (ILVS) comprised of a biodegradable citric acid-based elastomeric polymer, referred to as methacrylated polydiol citrate (mPDC) and a diazeniumdiolate chitosan nitric oxide donor (chitoNO). In vitro studies demonstrate that the mechanical properties of the ILVS can be tailored to meet or exceed those of commercially available self-expanding bare metal stents (BMS). The radial compression strength of the ILVS is higher than that of a BMS despite undergoing degradation at physiologic conditions for 7 months. ILVS containing chitoNO provides sustained supraphysiologic levels of NO release. Finally, ILVS is successfully cast in porcine arteries ex vivo using a custom designed triple balloon catheter, demonstrating translational potential. In conclusion, these data demonstrate the ability of an ILVS to provide tunable mechanical properties and drug-delivery capabilities for the vasculature and thereby support mPDC as a promising material for the development of novel BVS platforms.",
author = "Albaghdadi, {Mazen S.} and Jian Yang and Brown, {Jessica H.} and Mansukhani, {Neel A.} and Ameer, {Guillermo A.} and Kibbe, {Melina R.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1002/admt.201600243",
language = "English (US)",
volume = "2",
journal = "Advanced Materials Technologies",
issn = "2365-709X",
publisher = "Wiley-Blackwell",
number = "4",

}

Albaghdadi, MS, Yang, J, Brown, JH, Mansukhani, NA, Ameer, GA & Kibbe, MR 2017, 'A Tailorable In Situ Light-Activated Biodegradable Vascular Scaffold', Advanced Materials Technologies, vol. 2, no. 4, 1600243. https://doi.org/10.1002/admt.201600243

A Tailorable In Situ Light-Activated Biodegradable Vascular Scaffold. / Albaghdadi, Mazen S.; Yang, Jian; Brown, Jessica H.; Mansukhani, Neel A.; Ameer, Guillermo A.; Kibbe, Melina R.

In: Advanced Materials Technologies, Vol. 2, No. 4, 1600243, 01.01.2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A Tailorable In Situ Light-Activated Biodegradable Vascular Scaffold

AU - Albaghdadi, Mazen S.

AU - Yang, Jian

AU - Brown, Jessica H.

AU - Mansukhani, Neel A.

AU - Ameer, Guillermo A.

AU - Kibbe, Melina R.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Biodegradable vascular scaffolds (BVS) are novel treatments for obstructive atherosclerotic cardiovascular disease developed to overcome the limitations of traditional metallic drug-eluting stents. The mechanical properties of bioabsorbable polymers used for the production of novel BVS are a key consideration for the clinical translation of this emerging technology. Herein, the authors describe the engineering of an in situ light-activated vascular scaffold (ILVS) comprised of a biodegradable citric acid-based elastomeric polymer, referred to as methacrylated polydiol citrate (mPDC) and a diazeniumdiolate chitosan nitric oxide donor (chitoNO). In vitro studies demonstrate that the mechanical properties of the ILVS can be tailored to meet or exceed those of commercially available self-expanding bare metal stents (BMS). The radial compression strength of the ILVS is higher than that of a BMS despite undergoing degradation at physiologic conditions for 7 months. ILVS containing chitoNO provides sustained supraphysiologic levels of NO release. Finally, ILVS is successfully cast in porcine arteries ex vivo using a custom designed triple balloon catheter, demonstrating translational potential. In conclusion, these data demonstrate the ability of an ILVS to provide tunable mechanical properties and drug-delivery capabilities for the vasculature and thereby support mPDC as a promising material for the development of novel BVS platforms.

AB - Biodegradable vascular scaffolds (BVS) are novel treatments for obstructive atherosclerotic cardiovascular disease developed to overcome the limitations of traditional metallic drug-eluting stents. The mechanical properties of bioabsorbable polymers used for the production of novel BVS are a key consideration for the clinical translation of this emerging technology. Herein, the authors describe the engineering of an in situ light-activated vascular scaffold (ILVS) comprised of a biodegradable citric acid-based elastomeric polymer, referred to as methacrylated polydiol citrate (mPDC) and a diazeniumdiolate chitosan nitric oxide donor (chitoNO). In vitro studies demonstrate that the mechanical properties of the ILVS can be tailored to meet or exceed those of commercially available self-expanding bare metal stents (BMS). The radial compression strength of the ILVS is higher than that of a BMS despite undergoing degradation at physiologic conditions for 7 months. ILVS containing chitoNO provides sustained supraphysiologic levels of NO release. Finally, ILVS is successfully cast in porcine arteries ex vivo using a custom designed triple balloon catheter, demonstrating translational potential. In conclusion, these data demonstrate the ability of an ILVS to provide tunable mechanical properties and drug-delivery capabilities for the vasculature and thereby support mPDC as a promising material for the development of novel BVS platforms.

UR - http://www.scopus.com/inward/record.url?scp=85038410596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038410596&partnerID=8YFLogxK

U2 - 10.1002/admt.201600243

DO - 10.1002/admt.201600243

M3 - Article

C2 - 29578542

AN - SCOPUS:85038410596

VL - 2

JO - Advanced Materials Technologies

JF - Advanced Materials Technologies

SN - 2365-709X

IS - 4

M1 - 1600243

ER -